Vaccine Race is Over: Ready or Not?


Volume/Issue : Volume 6 - 2021, Issue 1 - January

Google Scholar :

Scribd :

The coronavirus disease 19 (COVID-19) is a profoundly communicable and pathogenic viral disease brought about by serious intense respiratory disorder Covid 2 (SARS-CoV-2), which arose in Wuhan, China, and spread far and wide. The genomic examination uncovered that SARS-CoV-2 is phylogenetically identified with an extremely intense respiratory disorder like (SARS-like) bat infections, in this way bats could be the conceivable essential store. The middle wellspring of roots and move to people isn't known, in any case, the quick human to human exchange has been affirmed broadly. There is no clinically endorsed antiviral medication or vaccine accessible to be utilized against COVID-19. Nonetheless, hardly any expansive range of antiviral medications have been considered in contrast to COVID-19 in clinical preliminaries, brought about clinical recuperation. As of this composition, different countries have just asserted the viability of the vaccine they have as of late defined and have offered the world the fix to end this pandemic. In this paper, we will introduce the current circumstance worldwide on the rise of different vaccines for Covid-19 and how countries are fighting out to reserve a spot. We will perceive how underdeveloped nations will battle for their privileges too in procuring these vaccines. We will inspect the odds of the Philippines in sourcing vaccines for us all and assess the suppositions of the Filipinos on the immunization from China being offered by the public authority for nothing.

Keywords : Vaccine race, Covid -19 vaccine, Ready or not, Coronavirus.


Paper Submission Last Date
31 - October - 2021

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.